CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to improve prostate cancer treatment by studying non-coding RNAs (ncRNAs) that may play a role in tumor development and progression. It focuses on identifying biomarkers for early diagnosis and developing targeted therapies for advanced cases, ultimately enhancing patient outcomes and reducing healthc…
Annually, over 200 000 new prostate cancer cases are diagnosed in Europe.
This number is expected to further increase due to widespread use of prostate specific antigen (PSA) tests on asymptomatic men and an aging population.
This leads to high rate of over-detection, where most cases will never experience cancer symptoms during their lifetime.
Hence, our current lack of means to predict prostate cancer prognosis will have devastating impact on both life-quality and health care expenditures.
Mol…
TAMPEREEN YLIOPISTO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Rotterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Sheffield
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Lund
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Denmark, VEDBAEK
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
